Cargando…
Dapagliflozin protects neural and vascular dysfunction of the retina in diabetes
INTRODUCTION: Dapagliflozin, a sodium-glucose transporter inhibitor, effectively reduces blood glucose and is indicated for individuals with kidney diseases and cardiovascular disorders. In this study, we further expand the therapeutic benefit of dapagliflozin in the neural and vascular retina, with...
Autores principales: | Luo, Qianyi, Leley, Sameer P, Bello, Erika, Dhami, Hurshdeep, Mathew, Deepa, Bhatwadekar, Ashay Dilip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114950/ https://www.ncbi.nlm.nih.gov/pubmed/35577387 http://dx.doi.org/10.1136/bmjdrc-2022-002801 |
Ejemplares similares
-
Per2 Mutation Recapitulates the Vascular Phenotype of Diabetes in the Retina and Bone Marrow
por: Bhatwadekar, Ashay D., et al.
Publicado: (2013) -
Sickle Cell Trait Worsens Oxidative Stress, Abnormal Blood Rheology, and Vascular Dysfunction in Type 2 Diabetes
por: Diaw, Mor, et al.
Publicado: (2015) -
En face slab optical coherence tomography imaging successfully monitors progressive degenerative changes in the innermost layer of the diabetic retina
por: Katsuyama, Atsuko, et al.
Publicado: (2020) -
Histamine causes an imbalance between pro-angiogenic and anti-angiogenic factors in the retinal pigment epithelium of diabetic retina via H4 receptor/p38 MAPK axis
por: Lee, Byung Joo, et al.
Publicado: (2020) -
miR-92a Corrects CD34(+) Cell Dysfunction in Diabetes by Modulating Core Circadian Genes Involved in Progenitor Differentiation
por: Bhatwadekar, Ashay D., et al.
Publicado: (2015)